{"id":1315449,"title":"DSEN Abstract: Crizotinib and Incidence of Death: A Systematic Review and Network Meta-analysis of ALK Inhibitors for Non-small Cell Lung Cancer - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-04","captureTimestamp":"2026-02-04T10:27:27.938000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/54496.html","snippet":"DSEN Abstract Crizotinib and Incidence of Death: A Systematic Review and Network Meta-analysis of ALK Inhibitors for Non-small Cell Lung Cancer Summary We observed that all ALK inhibitors improved progression-free survival relative to chemotherapy, and that alectinib and…","rawSnapshotUrl":"/api/snapshots/raw/1315449","browseUrl":"https://replay.healtharchive.ca/job-8/20260204102727/https://cihr-irsc.gc.ca/e/54496.html#ha_snapshot=1315449","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}